Philip D. Gregory, Chief Scientific Officer at bluebird bio, Inc. (BLUE), sold 250 shares at $86.66 ($22K) on 2020-01-06, disclosed to the SEC on 2020-01-08.
Scheduled sale ($22k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TSVT | SELL | 2023-08-24 | $34K | — | Filing → |
| TSVT | SELL | 2023-08-07 | $24K | — | Filing → |
| TSVT | SELL | 2023-01-18 | $11K | — | Filing → |